CONTENTS:
- Editorial: AI and new digital technologies have transformed alcohol and other drug industries lobbying. Rychert M., Sultan A., Mialon M., p. 1-5.
- How accurate are drug cryptomarket listings by content, weight, purity and repeat purchase? Barratt M.J., Coomber R., Kowalski M., Aldridge J., Munksgaard R., Ferris J., et al., p. 6-18.
- Sociodemographic differences and experienced effects of young adults who use cannabis mainly for self-medication versus recreationally in Finland. Hupli A., Unlu A., Jylkkä J., Oksanen A., p. 19-36.
- "No, my name's not on the lease at all": An interpretive phenomenological analysis of unstable housing and hepatitis C among people who inject drugs. McColl R., Higgs P., Harney B., p. 37-50.
- The receipt of medications for opioid use disorder among pregnant individuals in the USA: a multilevel analysis. Curran L., Manuel J., p. 51-66.
- Cultural variations in conceptualization of excessive drinking among young adults in Denmark, Estonia and Italy. Rolando S., Cuomo G., Allaste A.-A., Fabricius V.A.V., Kolind T., Läänemets M., p. 67-82.
- Implications of legalisation of cannabis cultivation in Ghana: a critical review. Agboli J.M., p. 83-96.
- Pandemic-related changes in alcohol use among LGB+ people with and without mental health and neurodevelopmental conditions: a multinational cross-sectional study. Connolly D.J., Gilchrist G., Ferris J., Puljevic C., Maier L., Barratt M.J., et al., p. 97-109.